Clinical Trial Update: A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing Avastin (bevacizumab) with irinotecan versus temozolomide-based radiochemotherapy in patients with glioblastoma, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Avastin (bevacizumab)
• Irinotecan (Irinotecan)
• Temodar (Temozolomide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED | Results posted: 2015-11-20